- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Citius Pharmaceuticals (NASDAQ:CTXR), Quotes and News Summary
Citius Pharmaceuticals (NASDAQ: CTXR)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.050 | -0.060 | -0.0100 | ||||
| REV | 0 |
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.050 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Citius Pharmaceuticals Questions & Answers
You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.
Other companies in Citius Pharmaceuticals’s space includes: Xeris Biopharma Holdings (NASDAQ:XERS), Satsuma Pharmaceuticals (NASDAQ:STSA), Terns Pharma (NASDAQ:TERN), Marinus Pharma (NASDAQ:MRNS) and Harrow Health (NASDAQ:HROW).
The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by HC Wainwright & Co. on Tuesday, January 18, 2022. The analyst firm set a price target for 6.00 expecting CTXR to rise to within 12 months (a possible 400.00% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.2 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Citius Pharmaceuticals.
Citius Pharmaceuticals’s Q3 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Citius Pharmaceuticals.
Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.